Global Parenteral Nutrition Industry To 2027 – Higher Prevalence Of Different Chronic Diseases Boosts Growth | News

DUBLIN, 22 December 2021 / PRNewswire / – The “Global Parenteral Nutrition Market By Nutrient Type (Single Dose Amino Acid Solution, Parenteral Fat Emulsion, Carbohydrates, Trace Elements, and Vitamins & Minerals), By Regional Outlook, COVID Impact Analysis Report and Forecast -19, 2021-2027 “ the report was added to‘s offer.

The global parenteral nutrition market size is expected to reach $ 10.9 billion by 2027, increasing to a market growth of 8.1% CAGR during the forecast period.

Parenteral nutrition (parenteral nutrition), or intravenous feeding, provides liquid nutrients such as proteins, vitamins, fats, electrolytes, minerals, and carbohydrates. It is a component of specialized nutritional therapy that provides nutritional support to patients who are unable to properly use their gastrointestinal tract. It is extremely helpful in eliminating malnutrition and maintaining hydration, energy and strength levels. For this reason, it is widely used in patients with cancer, hydration, Crohn’s disease, ischemic bowel disease, short bowel syndrome, and abnormal bowel function.

The development of the parenteral nutrition market is expected to be fueled by the increasing prevalence of malnutrition in children, mainly in emerging and underdeveloped countries all over the world. Moreover, the requirement of parenteral nutrition (parenteral nutrition) to appropriately balance amino acids, fats, vitamins, minerals and other nutrients is expected to create good growth prospects for the growth of the market of parenteral nutrition.

Adopting parenteral nutrition should be nourishing as it reduces the risk of underdevelopment and infection. Very low birth weight (VLBW) infants are witnessing a huge demand for parenteral nutrition products due to the low possibility of enteral nutrition (EN). In addition, an increased acceptance of parenteral nutrition for premature infants, which results in better neurological growth, improved intrauterine nutrient deposition and reduced the risk of complications, thereby improving their chances of survival.

COVID-19 impact assessment

The outbreak of the COVID-19 pandemic has dramatically increased the rate of adoption of parenteral nutrition to provide the nutrition and fluids the body needs for rapid and safe recovery. In addition, the growing acceptance of the administration of parenteral nutrition over enteral feeding in patients with COVID-19 to meet required nutritional needs, increasing nutrient absorption and increasing nutrient absorption. decreased risk of infection should accelerate demand. & growth of the overall parenteral nutrition market in the coming years.

Additionally, the increasing adoption of these formulations among clinicians to help patients achieve their target nutritional intake, improve recovery, and reduce hospital stays are some of the factors propelling the development of the global Grapefruit market. parenteral nutrition.

Market growth factors:

The skyrocketing rate of malnutrition among the world’s population

In addition, the governments of many countries are undertaking various initiatives with the aim of reducing the growing burden of malnutrition, thereby increasing the demand for intravenous feeding. Various government organizations such as Action Against Hunger, Food4Africa, Heifer International and the World Health Organization are ready to take new initiatives to provide better treatment to people suffering from malnutrition.

Higher prevalence of different chronic diseases

Various types of diseases like head and neck cancer, esophageal cancer, Crohn’s disease, ulcerative colitis, stomach cancer, and laryngeal cancer can impact the consumption of oral food in patients. Due to their growing appearance, the global parenteral nutrition market is expected to be propelled in the coming years.

Market restriction factor:

A growing trend in enteral nutrition

The preference for enteral nutrition is steadily increasing among patients around the world. Medical specialists generally suggest the use of enteral nutrition over parenteral nutrition. This is because it is cheaper, can be easily administered, and has fewer complications. In addition, enteral feeding enables better and efficient nutrient uptake and supports the body’s natural healing process by stimulating intestinal blood flow.

Outlook Nutrient Type

On the basis of nutrient type, the market is segmented into single dose amino acid solution, parenteral fat emulsion, carbohydrate, trace elements, and vitamins and minerals. The parenteral lipid emulsions segment is expected to show the fastest growth rate during the forecast period. The increase in hospital malnutrition cases is the main factor driving the demand for parenteral lipid emulsions by delivering non-protein calories and essential fatty acids to patients, decreasing inflammation, and improving metabolic and clinical outcomes. In addition, the segment demand in hospitals is expected to be driven by the increasing demand for critically ill patients and the high rates of chronic diseases such as inflammatory bowel disease, cancer and diabetes.

Regional perspectives

On the basis of regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. Asia Pacific is expected to show the fastest growth rate during the forecast period. The regional market is expected to be driven by economic growth in different countries like India, Japan, and China and supporting government initiatives as well as favorable reimbursement policies and the growth of the health care sector. In addition, the increase in the frequency of chronic diseases, the growing awareness of the benefits of nutrient types, and the growing number of parenteral nutrition users in some of the emerging countries in this region are expected to create new growth avenues for the players operating in the regional parenteral nutrition market over the forecast years.

The market research report covers the analysis of the major players in the market. Major companies featured in the report include Vifor Pharma Management Ltd., Baxter International, Inc., Allergan PLC (AbbVie), B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Grifols SA, Pfizer, Inc., ICU Medical, Inc.., Anhui Medipharm Co., Ltd. and Aculife Healthcare Private Limited.

Main topics covered:

Chapter 1. Market Scope and Methodology

Chapter 2. Market Overview

2.1 Presentation

2.1.1 Overview Impact of COVID-19 Market composition and scenario

2.2 Key factors influencing the market

2.2.1 Market drivers

2.2.2 Market restrictions

Chapter 3. Global Parenteral Nutrition Market by Nutrient Type

3.1 Global Single Dose Amino Acid Solutions Market by Region

3.2 Global Parenteral Lipid Emulsions Market by Region

3.3 Global Carbohydrate Market by Region

3.4 Global Trace Elements Market by Region

3.5 Global Other Types of Nutrients Market by Region

Chapter 4. Global Parenteral Nutrition Market by Region

Chapter 5. Company Profiles

5.1 Vifor Pharma Management SA

5.1.1 Company overview

5.1.2 Financial analysis

5.1.3 Research and development costs

5.2 Baxter International, Inc.

5.2.1 Company overview

5.2.2 Financial analysis

5.2.3 Regional analysis

5.2.4 Research and development costs

5.2.1 Recent strategies and developments: Partnerships, collaborations and agreements: Product launches and product extensions: Approvals and trails:

5.3 Allergan PLC (AbbVie)

5.3.1 Company overview

5.3.2 Financial analysis

5.3.3 Regional analysis

5.3.4 Research and development costs

5.4B. Braun Melsungen AG

5.4.1 Company overview

5.4.2 Financial analysis

5.4.3 Sector and regional analysis

5.4.4 Research and development costs

5.5 Fresenius SE & Co. KGaA

5.5.1 Company overview

5.5.2 Financial analysis

5.5.3 Sectoral and regional analysis

5.5.4 Research & Development costs

5.6 Grifol SA

5.6.1 Company overview

5.6.2 Financial analysis

5.6.3 Sectoral and regional analysis

5.6.4 Research and development costs

5.7 Pfizer, Inc.

5.7.1 Company overview

5.7.2 Financial analysis

5.7.3 Regional analysis

5.7.4 Research and development costs

5.8 ICU Medical, Inc.

5.8.1 Company overview

5.8.2 Strategies and recent developments: Partnerships, collaborations and agreements:

5.9 Anhui Medipharm Co., Ltd.

5.9.1 Company overview

5.10. Aculife Private Health Limited

5.10.1 Company overview

For more information on this report, visit

Media contact:

Research and markets

Laura Wood, senior

For EST office hours, call + 1-917-300-0470

For USA / CAN call toll free + 1-800-526-8630

For GMT office hours, call + 353-1-416-8900

US Fax: 646-607-1904

Fax (outside the United States): + 353-1-481-1716

Show original content:—higher-prevalence-of-different-chronic-diseases-is-driving-growth-301449842.html

SOURCE Research and Markets